The SUSTAIN clinical trial program, which evaluated semaglutide for type 2 diabetes, and the STEP trials for weight management provide the most comprehensive safety data available
Future research should prioritize elucidating the molecular mechanisms behind the antitumor effects, refining individualized treatment strategies, investigating early tumor prevention applications, assessing potential benefits for non-diabetic populations, advancing the development of novel therapies, establishing robust safety monitoring frameworks, and building precision medicine decision-making platforms
[DOI] [PMC free article] [PubMed] [Google Scholar] 95.Pu Z., Yang Y., Qin S., Li X., Cui C., Chen W
Articular cartilage, mostly consisting of chondrocytes and ECM, is the primary locus of basic aetiology of OA [38]
It is not approved by the FDA for clinical use
However, as your body adapts, monitoring which forms of folate and B12 work best for you is essential